Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big Yellow to consider a strategic sale to maximize shareholder returns, noting the shares trade at a 40% discount to net asset value. The stock trades around $10.99 with a market cap of about $2.15 billion. No potential buyers or sale prices have been disclosed yet, and Big Yellow has not responded to the calls for a review. This situation highlights potential value opportunities for investors if a sale or strategic action occurs.
Big Yellow Group is noted here with Jefferies maintaining a Buy rating. For readers following the Real Estate sector, here is Pluang's market snapshot as of Oct 14, 2026 23:12 WIB: out of 47 priced US Real Estate stocks tradable on Pluang, 7 rose and 40 fell. Notable movers include EQIX at USD 998.87 with a 1-day change of -2.01% and a typical hold time on Pluang of 110 days, MAC at USD 22.08 down 2.00%, and JAN at USD 28.30 down 1.91%.
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
State Street reported its Q3 2026 earnings with adjusted EPS of $3.69, slightly above the $3.68 estimate, marking its fourth consecutive quarterly earnings beat. Revenue rose 13% year-over-year to about $4 billion but missed analyst expectations of $...
